483 Xellia Pharmaceuticals USA May 2017

483 Xellia Pharmaceuticals USA May 2017

$119 - Not in Stock

FDA investigators audited the Xellia Pharmaceuticals USA - Raleigh, NC, United States facility and issued inspectional observations (via FDA 483) on 19 May 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 19 May 2017
  • Location: Raleigh, United States
  • FEI: 3005208599

Pre-Order Not Available